Skip to main content
SpringerLink
Log in

Plummer’s disease: localized thyroid autonomy

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Plummer H.S. The clinical and pathological relationship of simple and exophthalmic goiter. Am. J. Med. Sci. 146: 790, 1913.

    Google Scholar 

  2. Cope O., Rawson R.W., McArthur J.W. The hyperfunctioning single adenoma of the thyroid. Surg. Gynecol. Obstet. 84: 415, 1947.

    CAS  PubMed  Google Scholar 

  3. Dobyns B.M., Skanse B., Maloof F. A method for the preoperative estimation of function in thyroid tumors: Its significance in diagnosis and treatment. J. Clin. Endocrinol. Metab. 9: 1171, 1949.

    CAS  PubMed  Google Scholar 

  4. Horst W. Neue Ergebnisse der Anwendung von J131 in Diagnostik und Therapie von Schilddrüsenerkrankungen. Verh. Dtsch. Ges. Verdauungs- u. Stoffwechselkr. 17: 152, 1953.

    Google Scholar 

  5. Horst W. Klinische Radiojoddiagnostik der Schilddrüsenerkrankungen. In: Schinz H.R. (Ed.), Strahlenbiologie, Strahlentherapie, Nuklearmedizin und Krebsforschung. Thieme Verlag, Stuttgart, 1959, p. 785.

    Google Scholar 

  6. Hôfer R., Vetter H. Scanning in non-cancerous thyroid disease. In: Medical Radioisotope Scanning. IAEA, Vienna, 1959, p. 213.

    Google Scholar 

  7. Sheline G.E., McCormack K. Solitary hyperfunctioning thyroid nodules. J. Clin. Endocrinol. Metab. 20: 1401, 1960.

    CAS  Google Scholar 

  8. Miller J.M., Horn R.C., Block M.A. The evolution of toxic nodular goiter. Arch. Intern. Med. 113: 72, 1964.

    CAS  PubMed  Google Scholar 

  9. Solomon D.H. Factors affecting the fractional rate of release of radioiodine from the thyroid gland in man. Metabolism 5: 667, 1956.

    CAS  PubMed  Google Scholar 

  10. Molnar G.D., Wilber R.D., Lee R.E., Woolner L.B., Keating F.R. Jr. On the hyperfunctioning solitary thyroid nodule. Mayo Clin. Proc. 40: 665, 1965.

    CAS  PubMed  Google Scholar 

  11. Charkes N.D. Scintigraphic evaluation of nodular goiter. Semin. Nucl. Med. 1: 316, 1971.

    CAS  PubMed  Google Scholar 

  12. Miller J.M. Plummer’s disease. Med. Clin. North Am. 59: 1203, 1975.

    CAS  PubMed  Google Scholar 

  13. Plummer H.S. The function of the thyroid gland containing adenomatous tissue. Trans. Ass. Am. Phys. 43: 159, 1928.

    Google Scholar 

  14. DeGroot L.J., Larsen P.R., Refetoff S., Stanbury J.B. The thyroid and its diseases, ed. 5. Wiley & Sons, New York, 1984, p. 743.

    Google Scholar 

  15. Wiener J.D. A systematic approach to the diagnosis of Plummer’s disease (autonomous goitre), with a review of 224 cases. Neth. J. Med. 18: 218, 1975.

    Google Scholar 

  16. Wiener J.D. Toxicity, nodularity, activity, autonomy — “coming to terms” in thyroid investigation. J. Nucl. Med. 12: 318, 1971.

    CAS  PubMed  Google Scholar 

  17. Studer H., Ramelli F. Simple goiter and its variants: Euthyroid and hyperthy-roid multinodular goiters. Endocr. Rev. 3: 40, 1982.

    CAS  PubMed  Google Scholar 

  18. Skillern P.G., McCullagh E.P., Clamen M. Radioiodine in diagnosis and therapy of hyperthyroidism: Hyperthyroidism caused by hyperfunctioning thyroid adenoma. Arch. Intern. Med. 110: 888, 1962.

    CAS  PubMed  Google Scholar 

  19. McKenzie J.M. Hyperthyroidism caused by thyroid adenomata. J. Clin. Endocrinol. Metab. 26: 779, 1966.

    CAS  PubMed  Google Scholar 

  20. Wils J.A., Kloppenborg P.W.C. De toxische schildkliernodus. Ned. Tijdschr. Geneeskil. 114: 880, 1970.

    CAS  Google Scholar 

  21. Adams D.D., Kennedy T.H., Stewart J.C., Utiger R.D., Vidor G.I. Hyperthyroidism in Tasmania following iodide supplementation: Measurements of thyroid-stimulating autoantibodies and thyrotropin. J. Clin. Endocrinol. Metab. 41: 221, 1975.

    CAS  PubMed  Google Scholar 

  22. Lamberg B.-A., Gordin A., Viherkoski M., Kvist G. Long-acting thyroid stimulator (LATS) in toxic nodular goiter, toxic adenoma and Graves’ disease. Acta Endocrinol. (Kbh.) 62: 199, 1969.

    CAS  Google Scholar 

  23. Charkes N.D. Graves’ disease with functioning nodules (Marine-Lenhart syndrome). J. Nucl. Med. 13: 885, 1972.

    CAS  PubMed  Google Scholar 

  24. Wiener J.D., van der Gaag R.D. Autoimmunity and the pathogenesis of localized thyroid autonomy (Plummer’s disease). Clin. Endocrinol. (Oxf.) 23: 635, 1985.

    CAS  Google Scholar 

  25. Miller J.M., Block M.A. Functional autonomy in multinodular goiter. JAMA 214: 535, 1970.

    CAS  PubMed  Google Scholar 

  26. Eller M., Silver S., Yohalem S.B., Segal R.L. The treatment of toxic nodular goiter with radioiodine: 10 years’ experience with 436 cases. Ann. Intern. Med. 52: 976, 1960.

    CAS  PubMed  Google Scholar 

  27. Coindet J.F. Nouvelles recherches sur les effets de l’iode, et sur les précautions à suivre dans le traitement du goitre par ce nouveau remède. Ann. Chim. Phys. (Paris) 16: 252, 1821.

    Google Scholar 

  28. Coindet J.F. Découverte d’un nouveau remède contre le goître. Ann. Chim. Phys. (Paris) 15: 49, 1820.

    Google Scholar 

  29. Wiener J.D. Über Krorpf, Hyperthyreose und Jodbehandlung. Hommage à Jean-François Coindet de Genève. Schweiz. Med. Wochenschr. 110: 1784, 1980.

    CAS  PubMed  Google Scholar 

  30. VanderLaan W.P., Caplan R. Observations on a relationship between total thyroid iodine content and the iodide-concentrating mechanism of the thyroid gland of the rat. Endocrinology 54: 437, 1954.

    CAS  PubMed  Google Scholar 

  31. Van Middlesworth L. Thyroxine accumulation in thyroids of hypophysectomized rats. Endocrinology 84: 375, 1969.

    PubMed  Google Scholar 

  32. Wöhler J., Heinze H.G., Pickardt C.R., Erhardt F., Scriba P.C. Eine neue, risikolose Methode zur Diagnostik dekompensierter autonomer Adenome der Schilddrüse. Dtsch. Med. Wochenschr. 99: 1240, 1974.

    PubMed  Google Scholar 

  33. Gerber H., Peter H.J., Ramelli F., Miloni E., König M.P., Studer H., Berchtold R., Gemsenjäger E. Autonomie und Heterogenität der Follikel in der euthyreoten und hyperthyreoten menschlichen Knotenstruma: die Lösung alter Rätsel? Schweiz. Med. Wochenschr. 113: 1178, 1983.

    CAS  PubMed  Google Scholar 

  34. Wollman S.H. Heterogeneity of the thyroid gland. In: Cassano C., Andreoli M. (Eds.), Current topics in thyroid research. Academic Press, New York, 1965, p. 1.

    Google Scholar 

  35. Burke G., Szabo M. Dissociation of in vivo and in vitro “autonomy” in hyperfunctioning thyroid nodules. J. Clin. Endocrinol. Metab. 35: 199, 1972.

    CAS  PubMed  Google Scholar 

  36. Toccafondi R., Rotella C.M., Tanini A., Aterini S., Borrelli D., Loddi L., Arcangeli P. Effects of TSH on cAMP levels and thyroid hormone release in human thyroid “autonomous” nodules: relationship with iodothyronine and iodine content in thyroglobulin. Clin, Endocrinol. (Oxf.) 17: 537, 1982.

    CAS  Google Scholar 

  37. Van Sande J., Mockel J., Boeynaems J.M., Dor P., Andry G., Dumont J.E. Regulation of cyclic nucleotide and prostaglandin formation in normal human thyroid tissue and in autonomous nodules. J. Clin. Endocrinol. Metab. 50: 776, 1980.

    PubMed  Google Scholar 

  38. Toccafondi R.S., Rotella C.M., Tanini A., Fani P., Arcangeli P. Thyrotrophin-responsive adenylate cyclase activity in thyroid toxic adenoma. Acta Endocrinol. (Kbh.) 92: 658, 1979.

    CAS  Google Scholar 

  39. Green W.L., Ingbar S.H. The effect of iodide on the rate of release of I131 from autonomous thyroid nodules. J. Clin. Invest. 41: 173, 1962.

    PubMed Central  CAS  PubMed  Google Scholar 

  40. Van Sande J., Lamy F., Lecocq R., Rickaert F., Demeester-Mirkine N. Abnormal cell regulation in the autonomous nodule. 9th International Thyroid Congress, Sao Paulo, 1985, abstr. 55.

  41. Miller J.M., Kawas B. The combined use of iodine-125 and iodine-131 in autoradiographic studies of nodular goiter. J. Nucl. Med. 7: 188, 1966.

    CAS  PubMed  Google Scholar 

  42. Miller J.M., Horn R.C., Block M.A. The autonomous functioning thyroid nodule in the evolution of nodular goiter. J. Clin. Endocrinol. Metab. 27: 1264, 1967.

    CAS  PubMed  Google Scholar 

  43. Taylor S. The evolution of nodular goiter. J. Clin. Endocrinol. Metab. 13: 1232, 1953.

    CAS  PubMed  Google Scholar 

  44. Studer H., Hunziker H.R., Ruchti C. Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters. Am. J. Med. 65: 227, 1978.

    CAS  PubMed  Google Scholar 

  45. Studer H. A fresh look at an old thyroid disease: euthyroid and hyperthyroid nodular goiter. J. Endocrinol. Invest. 5: 57, 1982.

    CAS  PubMed  Google Scholar 

  46. Peter H.J., Studer H., Forster R., Gerber H. The pathogenesis of “hot” and “cold” follicles in multinodular goiters. J. Clin. Endocrinol. Metab. 55: 941, 1982.

    CAS  PubMed  Google Scholar 

  47. Peter H.J., Gerber H., Studer H., Smeds S. Pathogenesis of heterogeneity in human multinodular goiter. A study on growth and function of thyroid tissue transplanted onto nude mice. J. Clin. Invest. 76: 1992, 1985.

    PubMed Central  CAS  PubMed  Google Scholar 

  48. Wiener J.D. Commentary on chapter 3. In: Hamburger J.I., Miller J.M. (Eds.), Controversies in clinical thyroidology. Springer-Verlag, New York, 1981, p. 95.

    Google Scholar 

  49. Belfiore A., Sava L., Runello F., Tomaselli L., Vigneri R. Solitary autonomously functioning thyroid nodules and iodine deficiency. J. Clin. Endocrinol. Metab. 56: 283, 1983.

    CAS  PubMed  Google Scholar 

  50. Bolk J.H., Elte J.W.F., Bussemaker J.K., Haak A., van der Heide D. Thyroid-stimulating immunoglobulins do not cause non-autonomous, autonomous, or toxic multinodular goitres. Lancet 2: 61, 1979.

    CAS  PubMed  Google Scholar 

  51. Brown R.S., Jackson I.M.D., Pohl S.L., Reichlin S. Do thyroid-stimulating immunoglobulines cause nontoxic and toxic multinodular goitre? Lancet 1: 904, 1978.

    CAS  PubMed  Google Scholar 

  52. Smyth P.P.A., Neylan D., O’Donovan D.K. The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay. J. Clin. Endocrinol. Metab. 54: 357, 1982.

    CAS  PubMed  Google Scholar 

  53. Leclere J., Bene M.C., Duprez A., Faure G., Thomas J.L., Vignaud J.M., Burlet C. Behaviour of thyroid tissue from patients with Graves’ disease in nude mice. J. Clin. Endocrinol. Metab. 59: 175, 1984.

    CAS  PubMed  Google Scholar 

  54. Schumm P.-M., Wenisch H.J.C., Schwedes U., Maul F.-D., Usadel K.-H. Untersuchungen zur Xenotransplantation von humanen benignen Schildrusengeweben auf thymusaplastische Nacktmäuse als Grundlage eines neuen Bioassays zur Bestimmung schilddrüsenstimulierender Immunglobuline (TSI) bei Hyperthyreose vom Typ Basedow. In: Schatz H., Doniach D. (Eds.), Autoimmunity in thyroid disorders. Thieme, Stuttgart, 1984, p. 52.

    Google Scholar 

  55. Cantor R.E., Charkes N.D. The effect of TSH on the solitary hyperfunctioning thyroid nodule. J. Nucl. Med. 8: 758, 1967.

    CAS  PubMed  Google Scholar 

  56. Vague J., Simonin R., Alland A., Ricciardi R., Kaphan G., Michel-Béchet M. Effets de la T.S.H. sur quelques nodules thyroïdiens sécrétants. Ann. Endocrinol. (Paris) 31: 666, 1970.

    CAS  Google Scholar 

  57. Soin J.S., Beal W., Burdine J.A. Disappearance of autonomous thyroid nodule under TSH stimulation. J. Nucl. Med. 15: 1209, 1974.

    CAS  PubMed  Google Scholar 

  58. Ducassaou D., Gasparoux S., Leccia F., Latapie J.-L., Hugues A. Aspects scintigraphiques inhabituels du nodule chaud thyroïdien. Problèmes diagnostiques. Nouv. Presse Méd. 4: 871, 1975.

    Google Scholar 

  59. Hazard J., Perlemuter L., Galle P., Melliere D., Gouygou C., Pinaudeau Y., Yomtov B. Nodules thyroïdiens sécrétans semblant se vider sous T.S.H. Ann. Endocrinol. (Paris) 33: 64, 1972.

    CAS  Google Scholar 

  60. Ingrisch H., Heinze H.G., Wöhler J., Horn K., Pfeifer K.J., Scriba P.C. Absolute Jodaufnahme autonomer Adenome der Schilddrüse vor und nach exogener TSH-Stimulation. Dtsch. Med. Wochenschr. 99: 1677, 1974.

    CAS  PubMed  Google Scholar 

  61. Decourt J., Savoie J.C., de Gennes J.L., Jungers P. L’adénome thyroïdien toxique, à la lumière des explorations par l’iode radio-actif. Etude de 24 observations. Sem. Hôp. Paris 38: 3317, 1962.

    Google Scholar 

  62. Bay V. Das toxische Adenom der Schilddrüse. Ergeb. Chir. Orthop. 47: 132, 1965.

    CAS  PubMed  Google Scholar 

  63. Horst W., Rösier H., Schneider C., Lahbhart A. 306 cases of toxic adenoma: Clinical aspects, findings in radioiodine diagnostics, radiochromatography and histology; results of 131I and surgical treatment. J. Nucl. Med. 8: 515, 1967.

    CAS  PubMed  Google Scholar 

  64. Hales I., Cowie G., Myhill J., Reeve T. Autonomous functioning nodules and thyrotoxicosis. Med. J. Aust. 1: 198, 1967.

    CAS  PubMed  Google Scholar 

  65. Joseph K., Mahlstedt J., Gonnermann R., Herbert K., Welcke U. Early recognition and evaluation of the risk of hyperthyroidism in thyroid autonomy in an endemic goiter area. J. Mol. Med. 4: 21, 1980.

    Google Scholar 

  66. Hamburger J.I., Werch S.C., Kadian G., Rossin H.W. The spectrum of autonomous function in thyroid nodules. Michigan Med. 67: 44 and 65, 1968 (cited in Yearbook Nucl. Med. 1969).

    Google Scholar 

  67. Savoie J.-C. Etude clinique et biologique de quarante-trois cas d’adénome toxique thyroïdien. Rev. Fr. Et. Clin. Biol. 6: 263, 1961.

    CAS  Google Scholar 

  68. Bricaire H., Joly J., Mathieu de Fossey R., Courjaret J., Baillet J. Exploration du couple hypophyso-thyroïdien à l’aide d’un dérivé de l’imidazol. A propos de 25 observations personnelles. Press. Méd. 72: 2505, 1964.

    CAS  PubMed  Google Scholar 

  69. Horst W., Petersen I., Thiemann K.J., Zukschwerdt L. Methoden und Ergebnisse der Differentialdiagnostik von Schilddrüsenerkrankungen durch die Szintigraphie und das Radiojod-Dreiphasenstudium. Dtsch. Med. Wochenschr. 85: 711, 1960.

    CAS  PubMed  Google Scholar 

  70. Vague J., Simonin R., Miller G., Alland A. Diagnosis and evolution of autonomous secreting thyroid nodules. In: Cassano C., Andreoli M. (Eds.), Current topics in thyroid research. Academic Press, New York, 1965, p. 883.

    Google Scholar 

  71. Ziliotto D., Conte N., Scandellari C. L’adenoma tossico della tiroide. Studio di 160 casi e rassegna della letteratura. Folia Endocrinol. (Roma) 19: 76, 1966.

    CAS  Google Scholar 

  72. Al Hindawi A.Y., Al-Hiti T.N., Baba W.l. Radioiodine in the diagnosis and therapy of solitary hyperfunctioning thyroid nodules. Nucl. Med. 7: 82, 1968.

    CAS  Google Scholar 

  73. Ferraz A., Medeiros-Neto G.A., Toledo A.C., Kieffer J. Autonomous thyroid nodules. I. A clinical classification and the use of a diagnostic index. J. Nucl. Med. 13: 733, 1972.

    CAS  PubMed  Google Scholar 

  74. Hamburger J.I. Should all autonomously functioning thyroid nodules be ablated to prevent the subsequent development of thyrotoxicosis? In: Hamburger J.I., Miller J.M. (Eds.), Controversies in clinical thyroidology. Springer-Verlag, New York, 1981, p. 69.

    Google Scholar 

  75. Fradkin J.E., Wolff J. Iodide-induced thyrotoxicosis. Medicine 62: 1, 1983.

    CAS  PubMed  Google Scholar 

  76. van Leeuwen E. Een vorm van genuïne hyperthyreose (M. Basedow zonder exophthalmus) na gebruik van gejodeerd brood. Ned. Tijdschr. Geneeskil. 98: 91, 1954.

    Google Scholar 

  77. Walthard B. Veränderungen der Schilddrüse durch Jodprophylaxe. Wien. Klin. Wochenschr. 80: 697, 1968.

    CAS  PubMed  Google Scholar 

  78. Connolly R.J., Vidor G.I., Stewart J.C. Increase in thyrotoxicosis in endemic goitre after iodination of bread. Lancet 1: 500, 1970.

    CAS  PubMed  Google Scholar 

  79. Maberly G.F., Corcoran J.M., Eastman C.J. The effect of iodized oil on goitre size, thyroid function and the development of the Jod Basedow phenomenon. Clin. Endocrinol. (Oxf.) 17: 253, 1982.

    CAS  Google Scholar 

  80. Vidor G.I., Stewart J.C., Wall J.R., Wangel A., Hetzel B.S. Pathogenesis of iodine-induced thyrotoxicosis: studies in northern Tasmania. J. Clin. Endocrinol. Metab. 37: 901, 1973.

    CAS  PubMed  Google Scholar 

  81. Ermans A.M., Camus M. Modifications of thyroid function induced by chronic administration of iodide in the presence of “autonomous” thyroid tissue. Acta Endocrinol. (Kbh.) 70: 463, 1972.

    CAS  Google Scholar 

  82. Joseph K., Mahlstedt J., Welcke U. Autonomously functioning thyroid tissue (AFTT) during iodide prophylaxis. J. Molec. Med. 4: 87, 1980.

    CAS  Google Scholar 

  83. Lobo L.C.G., Rosenthal D., Fridman J. Evolution of autonomous thyroid nodules. In: Cassano C., Andreoli M. (Eds.), Current topics in thyroid research. Academic Press, New York, 1965, p. 892.

    Google Scholar 

  84. Frey K.W., Heinze H.G., Kolb E. Radiojodbehandlung des multiplen autonomen Adenoms de Schilddrüse. Fortschr. Geb. Röntgenstr. 108: 586, 1968.

    CAS  Google Scholar 

  85. Oddie T.H., Fisher D.A., McConahey W.M., Thompson C.S. Iodine intake in the United States: A reassessment. J. Clin. Endocrinol. Metab. 30: 659, 1970.

    CAS  PubMed  Google Scholar 

  86. Spinelli-Ressi F. Le prove diagnostiche e la terapia con radioiodio nell’adenoma iperfunzionante. Minerva Med. 56: 2728, 1965.

    CAS  PubMed  Google Scholar 

  87. Wiener J.D. Long-term follow-up in untreated Plummer’s disease (autonomous goiter). Clin. Nucl. Med. 12: 198, 1987.

    CAS  PubMed  Google Scholar 

  88. Wiener J.D. Is partial thyroidectomy definitive treatment for Plummer’s disease (autonomous goiter)? Clin. Nucl. Med. 8: 78, 1983.

    CAS  PubMed  Google Scholar 

  89. Wiener J.D. Long-term follow-up after iodine-131 treatment for Plummer’s disease (autonomous goiter). Clin. Nucl. Med. 10: 256, 1985.

    CAS  PubMed  Google Scholar 

  90. Fellinger K., Höfer R., Egert H., Vetter H. Clinical and laboratory observations in patients with hyperactive thyroid nodules. In: Pitt-Rivers R. (Ed.), Advances thyroid research. Pergamon Press, New York, 1961, p. 347.

    Google Scholar 

  91. Dorta T. L’utilité de la scintigraphie pour le diagnostic des maladies thyroïdiennes et quelques considérations sur le métabolisme de l’iode du goïtre nodulaire. Schweiz., Med. Wochenschr. 90: 1344, 1960.

    CAS  Google Scholar 

  92. Górowski T., Chomicki O. Diagnosis of nontoxic “warm” thyroid nodules independent of TSH. J. Clin. Endocrinol. Metab. 22: 1267, 1962.

    PubMed  Google Scholar 

  93. Wiener J.D., Roos P. Thyroid asymmetry. Br. Med. J. 3: 312, 1968.

    PubMed Central  CAS  PubMed  Google Scholar 

  94. Wiener J.D., de Vries A.A.A. On the natural history of Plummer’s disease. Clin. Nucl. Med. 4: 181, 1979.

    CAS  PubMed  Google Scholar 

  95. Ng Tang Fui S., Maisey M.N., McColl I. Autonomous ectopic thyroid suppressing a normally situated gland, simulating a thyroglossal cyst: a case report. Br. J. Surg. 67: 143, 1980.

    Google Scholar 

  96. Demeester-Mirkine N., Ermans A.M. Euthyroid “hot” nodules: a physiological approach. In: Irvine W.J. (Ed.), Thyrotoxicosis. Livingstone, Edinburgh, 1967, p. 68.

    Google Scholar 

  97. Evered D.C., Clark F., Petersen V.B. Thyroid function in euthyroid subjects with autonomous thyroid nodules. Clin. Endocrinol. (Oxf.) 3: 149, 1974.

    CAS  Google Scholar 

  98. Blum M., Shenkman L., Hollander C.S. The autonomous nodule of the thyroid: Correlation of patient age, nodule size and functional status. Am. J. Med. Sci. 269: 43, 1975.

    CAS  PubMed  Google Scholar 

  99. Carpi A., Bianchi R., Zucchelli G.C., Toni M.G., Coli A., Levanti C., Mariani G. Thyroid hormone concentrations and inhibition of thyroid stimulating hormone secretion in euthyroid subjects with autonomous nodules. Eur. J. Clin. Invest. 7: 421, 1977.

    CAS  PubMed  Google Scholar 

  100. Reinwein D., Durrer H.A., Emrich D., Littmann K., Eilers E. The thyroidal T4/T3 ratio in autonomous adenomas: correlation with presurgical thyroid status and iodine content. Horm. Metab. Res. 9: 321, 1977.

    CAS  PubMed  Google Scholar 

  101. Ridgway E.C., Weintraub B.D., Cevallos J.L., Rack M.C., Maloof F. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J. Clin. Invest. 52: 2783, 1973.

    PubMed Central  CAS  PubMed  Google Scholar 

  102. Langer M., Madeddu G., Costanza C. Free thyroxine (FT4) and free triiodothyronine (FT3) in autonomous thyroid nodules. Clin. Endocrinol. (Oxf.) 11: 461, 1979.

    CAS  Google Scholar 

  103. Lerro S., Losa M., Trisorio M.T., Liuzzi A. Free thyroid hormone levels and TSH response to TRH in patients with autonomous thyroid adenomata and normal T3 and T4. Clin. Endocrinol. (Oxf.) 23: 373, 1985.

    CAS  Google Scholar 

  104. Solter M., Tišlarić D., Banovac K., Dominis M., Sekso M., Petek M., Pegan B., Petric V., Ivić Ž. Thyroidal thyroxine and triiodothyronine in autonomously functioning thyroid nodule and paranodular tissue. Exp. Clin. Endocrinol. 85: 369, 1985.

    CAS  PubMed  Google Scholar 

  105. Sugenoya A., Yamada Y., Kaneko G., Kobayashi M., Miyakawa M., Iida F. In vitro study on release of thyroid hormone in solitary autonomously functioning nodules using cell culture method. Endocrinol. Jpn. 31: 749, 1984.

    CAS  PubMed  Google Scholar 

  106. Sekso M., Vizner B., Škreb F. Augmented production of triiodothyronine in patients with autonomously functioning euthyroid adenoma. In: Carpi A. (Ed.), Thyroid function and dysfunction: modern concepts. ETS, Pisa, 1986, p. 85.

    Google Scholar 

  107. Elte J.W.F., Haak A., Wiarda K.S., Frölich M., van der Velde E.A., van der Heide D., Querido A. Propranolol improves the impaired TSH response to TRH in patients with autonomously functioning euthyroid multinodular goitre. Clin. Endocrinol. (Oxf.) 16: 553, 1982.

    CAS  Google Scholar 

  108. Gemsenjàger E. Further aspects of autonomy in euthyroid surgical patients. J. Mol. Med. 4: 59, 1980.

    Google Scholar 

  109. Wiener J.D., Lindeboom G.A. Studies of iodine metabolism in thyrotoxic crisis. In: Cassano C., Andreoli M. (Eds.), Current topics in thyroid research. Academic Press, New York, 1965, p. 1175.

    Google Scholar 

  110. Fuchsig P., Keminger K. Chirurgie der Schilddrüse — toxische Adenom. In: Oberdisse K., Klein E. (Eds.), Die Krankheiten der Schilddrüse. Thieme, Stuttgart, 1967, p. 568.

    Google Scholar 

  111. Blum M., Kranjac T., Park C.M., Engleman R.M. Thyroid storm after cardiac angiography with iodinated contrast medium: Occurrence in a patient with a previously euthyroid autonomous nodule of the thyroid. JAMA 235: 2324, 1976.

    CAS  PubMed  Google Scholar 

  112. Kocher T. Ueber Jodbasedow. Arch. Klin. Chir. 92: 1166, 1910.

    Google Scholar 

  113. Greer M.A. Jod-Basedow (or Jod-Coindet). N. Engl. J. Med. 288: 105, 1973.

    Google Scholar 

  114. Greene R., Farran H.E.A. On single “hot” nodules of the thyroid gland. J. Endocrinol. 33: 537, 1965.

    CAS  PubMed  Google Scholar 

  115. Shambaugh G.E. III, Quinn J.L., Oyasu R., Freinkel N. Disparate thyroid imaging: Combined studies with sodium pertechnetate Tc 99m and radioactive iodine. JAMA 228: 866, 1974.

    PubMed  Google Scholar 

  116. Turner J.W., Spencer R.P. Thyroid carcinoma presenting as a pertechnetate “hot” nodule, but without 131I uptake: Case report. J. Nucl. Med. 17: 22, 1976.

    CAS  PubMed  Google Scholar 

  117. Szonyi G., Bowers P., Allwright S., Ellis G., Wiseman J., Cooper R., Hales I. A comparative study of 99mTc and 131I in thyroid scanning. Eur J. Nucl. Med. 7: 444, 1982.

    CAS  PubMed  Google Scholar 

  118. Koutras D.A., Livadas D., Rigopoulos G.A., Sfontouris J., Malamos B., Iodine metabolism in autonomous hot nodules of the thyroid. Clin. Endocrinol. (Oxf.) 2: 249, 1973.

    CAS  Google Scholar 

  119. Miller J.M., Kasenter A.G., Marks D.S. Disparate imaging of the autonomous functioning thyroid nodule with 99mTc pertechnetate and radioiodine. Radiology 119: 737, 1976.

    CAS  PubMed  Google Scholar 

  120. Benassi E., Ollino P., Sannazzari G.L., Torretta A. I “nodi caldi tiroidei” studiati con la scintigrafia in tempi successivi. Radiol. Med. 48: 625, 1962.

    CAS  PubMed  Google Scholar 

  121. Usher M.S., Arzoumanian A.Y. Thyroid nodule scans made with pertechnetate and iodine may give inconsistent results. J. Nucl. Med. 12: 136, 1971.

    CAS  PubMed  Google Scholar 

  122. Atkins H.L., Klopper J.F., Lambrecht R.M., Wolf A.P. A comparison of technetium 99m and iodine 123 for thyroid imaging. Am. J. Roentgenol. 117: 195, 1973.

    CAS  Google Scholar 

  123. Arnold J.E., Pinsky S. Comparison of 99mTc and 123I for thyroid imaging. J. Nucl. Med. 17: 261, 1976.

    CAS  PubMed  Google Scholar 

  124. Dige-Petersen H., Kroon S., Vadstrup S., Andersen M.-L., Roy-Poulsen N.O. A comparison of 99mTc and 123I scintigraphy in nodular thyroid disorders. Eur. J. Nucl. Med. 3: 1, 1978.

    CAS  PubMed  Google Scholar 

  125. Shapiro B., Britton K., Fountos A., Granowska M., Hawkins L., Kiriaki P., Londres S., Nimmon C., Poston S. A multiobserver comparison of 99mTcO4 and 123I thyroid imaging. Eur. J. Nucl. Med. 6: 135, 1981.

    CAS  PubMed  Google Scholar 

  126. Ryo U.Y., Vaidya P.V., Schneider A.B., Bekerman C., Pinsky S.M. Thyroid imaging agents: A comparison of 1–123 and Tc-99m pertechnetate. Radiology 148: 819, 1983.

    CAS  PubMed  Google Scholar 

  127. Burke G. The triiodothyronine suppression test. Am. J. Med. 42: 600, 1967.

    CAS  PubMed  Google Scholar 

  128. Wallack M.S., Adelberg H.M., Nicoloff J.T. A thyroid suppression test using a single dose of L-thyroxine. N. Engl. J. Med. 283: 402, 1970.

    CAS  PubMed  Google Scholar 

  129. Levy R.P., Marshall J.S. Short-term drug effects on thyroid function tests. Arch. Intern. Med. 114: 413, 1964.

    CAS  PubMed  Google Scholar 

  130. Hüfner M., Gless K.-H. On the time course of thyrotropin suppression by high doses of thyroid hormones. Experientia 32: 655, 1976.

    PubMed  Google Scholar 

  131. Wenzel K.W., Meinhold H. Evidence of lower toxicity during thyroxine suppression after a single 3-mg L-thyroxine dose: Comparison to the classical L-triiodothyronine test for thyroid suppressibility. J. Clin. Endocrinol. Metab. 38: 902, 1974.

    CAS  PubMed  Google Scholar 

  132. Hainan K.E., Pochin E.E. The use of iodine 132 for thyroid function tests. Br. J. Radiol. 31: 581, 1958.

    Google Scholar 

  133. Heinze H.G., Wöhler J., Ingrish H., Pfeifer K.J., Souvatzoglou I., Horn K., Scriba P.C. TSH-stimulation mit niedrigen Dosen zur Diagnostik des autonomen Adenoms: Treffsicherheit und Risiko des TSH-tests. Dtsch. Med. Wochenschr. 99: 1236, 1974.

    CAS  PubMed  Google Scholar 

  134. Miller J.M., Hamburger J.I. The thyroid scintigram. I. The hot nodule. Radiology 84: 66, 1965.

    CAS  PubMed  Google Scholar 

  135. Ashkar F.S., Smoak W.M. III “Owl eye” sign of benign autonomous thyroid nodule. JAMA 214: 1563, 1970.

    CAS  PubMed  Google Scholar 

  136. Hamburger J.I. Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations. Am. J. Med. 58: 740, 1975.

    CAS  PubMed  Google Scholar 

  137. Silverstein G.E., Burke G., Cogan R. The natural history of the autonomous hyperfunctioning thyroid nodule. Ann. Intern. Med. 67: 539, 1967.

    CAS  PubMed  Google Scholar 

  138. Blum M., Nocero M.A. Jr. Spontaneous resolution of a euthyroid autonomous nodule of the thyroid. Am. J. Med. Sci. 264: 49, 1972.

    CAS  PubMed  Google Scholar 

  139. Ňemec J., Šmejkal V. Lasting disappearance of autonomously functioning thyroid nodule (AFTN) following the TSH stimulation test. Eur. J. Nucl. Med. 2: 143, 1977.

    PubMed  Google Scholar 

  140. Kammer H., Loveless M.O. Disappearance of hyperfunctioning thyroid nodule following TSH stimulation. J. Nucl. Med, 19: 1149, 1978.

    CAS  PubMed  Google Scholar 

  141. McCormack K.R., Sheline G.E. Long-term studies of solitary autonomous thyroid nodules. J. Nucl. Med. 8: 701, 1967.

    CAS  PubMed  Google Scholar 

  142. Miller J.M., Block M.A. The autonomous functioning nodule: Therapeutic considerations. Arch. Surg. 96: 386, 1968.

    CAS  PubMed  Google Scholar 

  143. Burman K.D., Earll J.M., Johnson M.C., Wartofsky L. Clinical observations on the solitary autonomous thyroid nodule. Arch. Intern. Med. 134: 915, 1974.

    CAS  PubMed  Google Scholar 

  144. Reinwein D., Gieshoff B., Ufacorro U., Interthal I., Strötges W., Emrich E. The natural course of the autonomous thyroid adenoma. Ann. Endocrinol. (Paris) 39: 59A, 1978 (abstract).

    Google Scholar 

  145. Blum M. Commentary on chapter 3. In: Hamburger J.I., Miller J.M. (Eds.), Controversies in clinical thyroidology. Springer-Verlag, New York, 1981, p. 81.

    Google Scholar 

  146. Hartman C.R., Morita E.T. Autonomous functioning multinodular goiters. J. Nucl. Med. 12: 436, 1971 (abstract).

    Google Scholar 

  147. Charkes N.D. Commentary on chapter 3. In: Hamburger J.I., Miller J.M. (Eds.), Controversies in clinical thyroidology. Springer-Verlag, New York, 1981, p. 88.

    Google Scholar 

  148. Hamburger J.I. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J. Clin. Endocrinol. Metab. 50: 1089, 1980.

    CAS  PubMed  Google Scholar 

  149. Miller J.M. Summary of chapter 3 and commentaries. In: Hamburger J.I., Miller J.M. (Eds.), Controversies in clinical thyroidology. Springer-Verlag, New York, 1981, p. 100.

    Google Scholar 

  150. Blum M., Biller B.J., Bergman D.A. The thyroid cork: Obstruction of the thoracic inlet due to retroclavicular goiter. JAMA 227: 189, 1974.

    CAS  PubMed  Google Scholar 

  151. Fisher D.A. Thyroid nodules in childhood and their management. J. Pediatr. 89: 866, 1976.

    CAS  PubMed  Google Scholar 

  152. Wiener J.D., Frensdorf E.L. Thyroid autonomy (Plummer’s disease) with contralateral malignancy — mere coincidence? Acta Med. Scand. 200: 509, 1976.

    CAS  PubMed  Google Scholar 

  153. Dorta T., Lemarchand-Béraud T., Burri C. Ein Fall von Schilddrüsenkarzinom mit hyperfunktionierenden Metastasen. Schweiz. Med. Wochenschr. 98: 701, 1968.

    CAS  PubMed  Google Scholar 

  154. McLaughlin R.P., Scholz D.A., McConahey W.M., Childs D.S. Jr. Metastatic thyroid carcinoma with hyperthyroidism: two cases with functioning metastatic follicular thyroid carcinoma. Mayo Clin. Proc. 45: 328, 1970.

    CAS  PubMed  Google Scholar 

  155. Rijnberk A., Der Kinderen P.J. Toxic thyroid carcinoma in the dog. Acta Endocrinol. (Kbh.) 138: 177, 1969 (abstract).

    Google Scholar 

  156. Hamburger J.I., Kadian G., Rossin H.W. Why not radioiodine therapy for toxic nodular goiter? Arch. Intern. Med. 119: 75, 1967.

    CAS  PubMed  Google Scholar 

  157. Ratcliffe G.E., Cooke S., Fogelman I., Maisey M.N. Radioiodine treatment of solitary functioning thyroid nodules. Br. J. Radiol. 59: 385, 1986.

    CAS  PubMed  Google Scholar 

  158. Heberling H.-J., Heintze M., Kuhlmann E., Lohmann D., Hartig W., Màttig H. Die thyreotrope Funktion der Hypophyse und die peripheren Schilddrüsenhormone nach Operation blander und autonomer Knotenstrumen. Dtsch. Med. Wochenschr. 109: 1757, 1984.

    CAS  PubMed  Google Scholar 

  159. Vagenakis A.G., Braverman L.E., Azizi F., Portnay G.I., Ingbar S.H. Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N. Engl. J. Med. 293: 681, 1975.

    CAS  PubMed  Google Scholar 

  160. Guinet P., Tourniaire J., Brière J., Pousset G. L’adénome toxique après intervention sur la thyroïde. Lyon Méd.: 459, 1968.

  161. Becker D.V., Hurley J.R. Complications of radioiodine treatment of hyperthyroidism. Semin. Nucl. Med. 1: 442, 1971.

    CAS  PubMed  Google Scholar 

  162. Miller J.M. Radioiodine therapy of the autonomous functioning thyroid. Semin. Nucl. Med. 1: 432, 1971.

    Google Scholar 

  163. Viherkoski M., Lamberg B.-A., Hernberg C.A., Niemi E. Treatment of toxic nodular and diffuse goiter with radioactive iodine. Late results and use of carbimazole. Acta Endocrinol. (Kbh.) 64: 159, 1970.

    CAS  Google Scholar 

  164. Holm L.-E., Lundell G., Israelsson A., Dahlqvist I. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. J. Nucl. Med. 23: 103, 1982.

    CAS  PubMed  Google Scholar 

  165. Goldstein R., Hart I.R. Follow-up of solitary autonomous thyroid nodules treated with 131I. N. Engl. J. Med. 309: 1472, 1983.

    Google Scholar 

  166. Hegedüs L., Veiergang D., Karstrup S., Hansen J.M. Compensated 131I-therapy of solitary autonomous thyroid nodules: effect on thyroid size and early hypothyroidism. Acta Endocrinol. (Kbh.) 113: 226, 1986.

    Google Scholar 

  167. Gilbert-Dreyfus Les adénomes toxiques de la thyroïde. Rev. Inform. Corps Méd. 3: 25, 1965.

    Google Scholar 

  168. Charkes N.D. High dose I-131 treatment of Plummer’s disease. J. Nucl. Med. 22: P6, 1981 (abstract).

    Google Scholar 

  169. Ng Tang Fui S.C., Maisey M.N. Standard dose 131I therapy for hyperthyroidism caused by autonomously functioning thyroid nodules. Clin. Endocrinol. (Oxf.) 10: 69, 1979.

    CAS  Google Scholar 

  170. Ross D.S., Ridgway E.C., Daniels G.H. Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism. Ann. Intern. Med. 101: 488, 1984.

    CAS  PubMed  Google Scholar 

  171. Gorman C.A., Robertson J.S. Radiation dose in the selection of 131I or surgical treatment for toxic thyroid adenoma. Ann. Intern. Med. 89: 85, 1978.

    CAS  PubMed  Google Scholar 

  172. Hamburger J.I., Meier D.A. Cancer following treatment of an autonomously functioning thyroid nodule with sodium iodide 131I. Arch. Surg. 103: 762, 1971.

    CAS  PubMed  Google Scholar 

  173. Robertson J.S., Gorman C.A. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. J. Nucl. Med. 17: 826, 1976.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Medicine, VU Ziekenhuis, 1007, MB Amsterdam, The Netherlands

    Jan D. Wiener

Authors
  1. Jan D. Wiener
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wiener, J.D. Plummer’s disease: localized thyroid autonomy. J Endocrinol Invest 10, 207–224 (1987). https://doi.org/10.1007/BF03347193

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347193

Key-words

Search

Navigation